Global Pain Management Drugs Market 2014-2018

News provided by

Research and Markets

01 May, 2014, 11:34 GMT

DUBLIN, May 1, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/33rr2c/global_pain) has announced the addition of the "Global Pain Management Drugs Market 2014-2018" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


The analysts forecast the Global Pain Management Drugs market will grow at a CAGR of 3.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing global aging population. The Global Pain Management Drugs market has also been witnessing intense competition among vendors. However, the increase in generic competition could pose a challenge to the growth of this market.

The report, the Global Pain Management Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Pain Management Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

You can request one free hour of our analyst's time when you purchase this market report. Details provided within the report.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Category

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

17. Key Vendor Analysis

18. Other Reports in this Series


Companies Mentioned: 

  • Abbott Laboratories
  • Actavis plc
  • Allergen Inc.
  • Astra Zenca plc
  • Baxter International Inc.
  • Bayer Healthcare AG
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corp.
  • Bristol Myers Squibb Co.
  • Durect Corp.
  • Eli Lilly and Co.
  • Endo Health Solutions Inc.
  • F. Hoffmann La Roche Ltd.
  • Forest Laboratories Inc.
  • GlaxoSmithKline plc
  • Hospira Inc.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pain Therapeutics Inc.
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Sanofi S.A.
  • St. Jude Medical Inc.
  • UCB S.A.
  • Valeant Pharmaceuticals International Inc.
  • Zalicus Inc.



For more information visit http://www.researchandmarkets.com/research/33rr2c/global_pain


Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net